Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
HIV
and visna lentiviruses induce an inflammatory reaction in the central nervous system (CNS) of the infected hosts leading to dysmyelination, demyelination, and neuronal loss. The basic domain of the transactivating Tat protein has been involved in CNS damage. Infusion of basic containing domain Tat peptides in the lateral ventricle (systemic injection) or in the grey matter, i.e., hippocampus and thalamus (local injection), induced an inflammatory process characterized by the formation of an edema and invasion of macrophage accompanied by reactive astrogliosis. Control peptides originating from either lentiviral proteins or irrelevant protein as ovalbumin did not lead to any inflammatory reaction or cell death. The inflammation led to the loss of ependymal cells in the lateral ventricles and neurons in the grey matter. RNA extracted from the Tat-injected hemisphere reacted with
TNF-alpha
, IL-1 alpha and beta, and IL-6 probes. The macrophage/microglia inducible nitric oxyde synthase was also expressed. Blockade of
TNF-alpha
by a pentoxifylline treatment led to the decrease of IL-1 and iNOS expression accompanied by a reduction of the volume of the lesions indicating that the Tat-induced lesions might be mediated by TNF production.
...
PMID:The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: involvement of cytokines. 752 41
IL-10 has been shown to be capable of down-regulating several aspects of macrophage function. This study was undertaken to define the association between IL-10 and
HIV
-1 infection in human macrophages. Infection of macrophages with a monocytotropic strain of the human immunodeficiency virus,
HIV
-BaL, resulted in expression of IL-10 mRNA within 3 to 12 h after infection, as determined by the reverse transcriptase PCR. Biologically active IL-10 was detected in supernatants from
HIV
-1-infected macrophages as early as 12 h post-infection. The addition of human rIL-10 to
HIV
-1-infected macrophage cultures resulted in a significant decrease in the viral replication. In addition, exogenous IL-10 blocked the ability of
TNF-alpha
to elevate viral replication. To determine whether IL-10 was associated with in vivo infection, lymph nodes from AIDS patients were examined for the presence of IL-10 mRNA by using PCR. IL-10 mRNA was evident in all lymph node tissue examined, but was absent in normal lymph node biopsies. These in vitro and in vivo findings demonstrate a strong and heterogeneous association between
HIV
-1 infection and IL-10.
...
PMID:IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. 752 49
Infection with human immunodeficiency virus type 1 (HIV-1) induces vigorous and persistent cytotoxic CD8+ T cell responses. CTL clones were derived from peripheral blood or cerebrospinal fluid of three
HIV
-1 patients, with depressed CD4+ T cell counts. When stimulated with HLA-compatible target cells (B-LCL) presensitized with cognate
HIV
-1 peptides, all clones produced GM-CSF,
TNF-alpha
, and IFN-gamma and most produced low amounts of IL2, IL3, and IL4. After nonspecific stimulation with a phorbol ester and calcium ionophore, the clones secreted cytokines at levels similar to those from CD4+ lines from an
HIV
-1 infected donor. The ability of supernatants from the stimulated CTL clones to support the formation of granulocyte-macrophage colonies in normal bone marrow suggests that the GM-CSF was biologically active. Release of cytokines by activated CTL may influence the immunopathogenesis of
HIV disease
.
...
PMID:Cytotoxic CD8+ T lymphocytes reactive with human immunodeficiency virus-1 produce granulocyte/macrophage colony-stimulating factor and variable amounts of interleukins 2, 3, and 4 following stimulation with the cognate epitope. 752 47
Inflammatory genes are regulated in cells of monocyte (Mo) lineage by a variety of cellular encounters, including adhesion mediated by integrins. The role of the beta 1 family of integrins in the direct induction of immediate early gene expression was analyzed by using the tissue factor (TF) gene. Engagement of alpha 4 or beta 1 on Mo, but not members of the beta 2 integrin family, with specific mAbs as surrogate ligands immediately and directly induced high level surface expression of TF, and accumulation of TF mRNA, as well as production of
TNF-alpha
and
HIV
-1 virus. The mechanism responsible for induction of TF gene transcription mediated by the engagement of alpha 4 or beta 1 was elucidated by using THP-1 monoblastic leukemia cells. Functional analysis of plasmids containing the TF promoter expressing the luciferase reporter gene identified a cis-acting integrin-responsive element (InRE), which contained two AP-1 sites as well as a single kappa B-like site. Mutation of either the AP-1 sites or kappa B-like site greatly diminished responsiveness to integrin engagement. This InRE also conferred responsiveness to a heterologous promoter in the same reporter plasmid. Binding of mAbs to either alpha 4 or beta 1 led to nuclear translocation of the c-Rel/p65 heterodimer that preferentially bound to the TF kappa B-like site. In contrast, constitutive binding of AP-1 proteins to the two AP-1 sites was not increased by alpha 4 or beta 1 integrin engagement. These studies expand knowledge of integrin regulation of immediate early gene expression in Mo and molecular encounters that are inferred to play an active role in Mo effector functions.
...
PMID:Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. 753 94
Human monocyte-derived macrophages (MDM) cultured in medium containing macrophage (M) CSF are more susceptible to infection with
HIV
-1. M-CSF increases the frequency with which MDM become infected, the level of
HIV
mRNA expressed per infected cell, and the level of proviral DNA expressed per infected culture. Because of these effects of M-CSF on
HIV
-1 replication and the reported function of this factor as a survival and differentiation factor for human monocytes, we investigated whether
HIV
-1 could induce endogenous M-CSF production by MDM and the potential role of endogenous M-CSF on
HIV
-1 infection in these cells. MDM infected with
HIV
and maintained in the absence of exogenous M-CSF produced this cytokine endogenously at levels 5- to 24-fold higher than uninfected cells. In contrast, the proinflammatory cytokines IL-1, IL-6, and
TNF-alpha
and the growth factor granulocyte-macrophage CSF were not detected. The kinetics of M-CSF production following infection paralleled the kinetics of virus replication. Furthermore, enhanced production of M-CSF was dependent on viral entry and active replication of
HIV
-1. Thus, endogenous M-CSF production may contribute to the survival of
HIV
-infected MDM, enable them to function as a reservoir for
HIV
, and facilitate the spread of virus in vivo.
...
PMID:Endogenous macrophage CSF production is associated with viral replication in HIV-1-infected human monocyte-derived macrophages. 753 9
The aim of the present study is to evaluate the relationship between the alpha tumor necrosis factor (
TNF-alpha
), interleukin 1 beta (IL-1 beta) and the neurological disease associated to the
HIV
-1 infection and different neurological manifestations (15 infections of the CNS and 11 AIDS-dementia complexes) and 14 from a control group. The mean value of
TNF-alpha
in CSF of patients with
HIV
-1 infection and AIDS-dementia complex was 19.8 +/- 30.6 pg/ml, superior to that of the control group (p < 0.05). The group of patients with
HIV
-1 and opportunistic CNS infection has a
TNF-alpha
value of 28.5 +/- 37.8 pg/ml, that is superior to that of the patients with the AIDS-dementia complex (
TNF-alpha
= 7.9 +/- 9.4 pg ml; p < 0.05). Within the group of patients with a CNS infection, the value of
TNF-alpha
was greater in those in the acute phase (44.2 +/- 42.4 pg/ml) than in those in the chronic phase (6.8 +/- 7.6 pg/ml; p < 0.05). The
TNF-alpha
in the CSF is a good marker of infection of the CNS in the
HIV
-1 infection.
...
PMID:[Alpha tumor necrosis factor in central nervous system disease associated with HIV infection]. 754 40
TNF-alpha
enhances
HIV
-1 replication in acutely and chronically infected cells and likely contributes to the wasting associated with the acquired immunodeficiency syndrome. Agents that inhibit
TNF-alpha
activity should theoretically delay the progression of disease, and several are currently in clinical trials. We hypothesized that IL-10, a cytokine that suppresses the gene expression and synthesis of
TNF-alpha
in monocytic cells, might inhibit
HIV
-1 replication. As expected, IL-10 suppressed PMA-induced
TNF-alpha
production in U1 cells; however, when U1 cells were cultured in the presence of PMA and increasing doses of IL-10, a dose-dependent increase in
HIV
-1 expression was observed. IL-10 also enhanced IL-1 beta-,
TNF-alpha
-, and GM-CSF-induced
HIV
-1 expression in U1 cells, and this occurred, at least in part, at the level of transcription. We next stimulated cells under conditions of
TNF-alpha
blockade. When PMA-induced
TNF-alpha
activity and
HIV
-1 replication were blocked by the presence of soluble TNF receptors, IL-10 independently enhanced
HIV
-1 replication. In contrast, other agents that are capable of blocking
TNF-alpha
synthesis or
TNF-alpha
activity either had no effect (IL-13 and IL-4) or inhibited
HIV
-1 expression (soluble TNF receptors and pentoxifylline) in U1 cells. These data suggest that IL-10, while inhibiting
TNF-alpha
synthesis, has an independent mechanism of action that enhances
HIV
-1 replication. Therefore, IL-10 may have undesirable effects in
HIV
-1-infected patients.
...
PMID:Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism. 755 27
Lymphocytes from patients with
HIV
-infection have been shown to undergo accelerated spontaneous apoptosis. Binding of CD4 molecules by
HIV
envelope protein gp120 and anti-gp120 antibodies can lead to crosslinking of CD4 molecules (CD4XL) in vitro and conceivably in vivo. We have recently shown that CD4XL in vitro, when performed in unfractioned peripheral blood mononuclear cells (PBMC) on normal
HIV
seronegative donors, is by itself sufficient to induce T cell apoptosis (Blood 82:3392, 1993). To further examine the mechanisms involved in apoptosis, we have examined the expression of Fas antigen (Fas) using 3 color flow cytometry. Fas is a cell surface molecule known to mediate apoptosis-triggering signals. We induced CD4XL in PBMC obtained from normal donors, either by anti-CD4 mAb Leu3a or by
HIV
-1 envelope protein gp160. PBMC subpopulations were examined for Fas Ag expression and for apoptosis induction by flow cytometry. CD4XL was found to result in increased Fas expression as well as Fas mRNA in lymphocytes and the up-regulated Fas Ag was closely correlated with apoptotic cell death. CD4XL in PBMC also resulted in induction of the cytokines INF-tau and
TNF-alpha
in the absence of IL-2 and IL-4 secretion. Both these cytokins contributed to Fas Ag up-regulation and antibodies to
TNF-alpha
and INF-tau abrogated CD4XL-induced Fas up-regulation and T-cell apoptosis. These findings suggest that CD4XL occurring in vivo might play an important role in inducing an abberant cytokine profile (which has been observed in
HIV
infected individuals) and also in triggering of T-cell apoptosis.
...
PMID:Mechanism of apoptosis in peripheral blood mononuclear cells of HIV-infected patients. 757 84
Monocyte/macrophages may harbor
HIV
in a nonproductive fashion for prolonged periods of time. Viral gene expression may be reactivated by stimulation of the cells with LPS or cytokines such as
TNF-alpha
in vitro. The effect of LPS and
TNF-alpha
is mediated by their ability to induce nuclear translocation of the DNA-binding heterodimer NF-kappa B (p50/p65), which binds to a specific sequence in the
HIV
-long terminal repeat. The present study demonstrates that triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) enhances viral replication in
HIV
-infected human monocytic cells. Monocytic cell lines and normal peripheral blood monocytes were infected with
HIV
-1 in vitro and cultured in the presence or absence of F(ab')2 fragments of monoclonal anti-CR1 or anti-CR3 Abs or with C3 fragments. Stimulation of CR1 or CR3 induces a two- to fourfold increase in the amount of cell-associated and released p24 Ag in cell cultures that was equivalent to that observed in control cultures triggered with LPS. We further observed that stimulation of CR1 or CR3 induces the nuclear translocation of NF-kappa B p50/p65 in infected cells. Translocation of NF-kappa B p50/p65 was also observed following stimulation of CR1 or CR3 of uninfected peripheral blood monocytes from
HIV
-seronegative donors. The amount of protein translocated was similar to that observed when cells were stimulated with rhTNF-alpha.
TNF-alpha
did not mediate the translocation of NF-kappa B p50/p65 induced by triggering of complement receptors. Taken together, these observations suggest that
HIV
gene expression may be activated in infected monocytes through interaction of the cells with complement-opsonized particles and that enhanced viral replication is associated with C3 receptor-mediated nuclear translocation of the NF-kappa B complex.
...
PMID:Triggering of complement receptors CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-kappa B (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells. 759 89
In
HIV
-1-infected asymptomatic carriers, the vast majority of infected cells in PBMCs are believed to be latently or nonproductively infected. We have isolated a subclone (MOLT-20-2) from an infected T cell line that expressed
HIV
-1 Ags at a very low level. However, viral Ag expression was markedly up-regulated by stimulation with either
TNF-alpha
, A23187, or PMA, indicating that the subclone might provide a suitable model of
HIV
-1 latency. Our previous studies have shown that the carboxyl-terminal region of the extracellular form of
HIV
-1 Nef played an important role in the interaction of infected cells with uninfected T cells, and could induce the cytostatic state. This suggested that Nef might contribute to intracellular signal transduction through an interaction with latently infected cells. We show in this study that stimulation of MOLT-20-2 with soluble Nef leads to
HIV
-1 activation from latency in a dose-dependent manner. Moreover, using a total of 14 overlapping Nef-related synthetic peptides, stimulatory activity was mapped to a discrete peptide (amino acid residues 132-147) that had the potential to activate latent
HIV
-1. This novel Nef function was confirmed by activation of virus production from the PBMCs of asymptomatic carriers. In addition, Nef-dependent
HIV
-1 activation from latency was also observed in another independently derived, latently infected cell line, U1, though not in cell line ACH-2. These results extend the significance of the Nef activity in vivo to the regulation of productive
HIV
-1 infection from latency, and define the regions of the protein involved.
...
PMID:Extracellular Nef protein regulates productive HIV-1 infection from latency. 759 42
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>